Key result
Cold crystalloid cardioplegia matches cold blood cardioplegia for preserving postoperative LVEF.
Why the study?
The optimal cardioplegic solution to use during aortic surgery remains unclear, as cold blood cardioplegia offers metabolic advantages while crystalloid cardioplegia offers practical benefits.
Does cold crystalloid cardioplegia provide noninferior preservation of postoperative left ventricular ejection fraction compared to cold blood cardioplegia in adult patients undergoing elective aortic arch replacement?
RCT (n=52)
Double-blind
Permuted block method (1:1 ratio, block size of 4)
No
Does cold crystalloid cardioplegia provide noninferior preservation of postoperative left ventricular ejection fraction compared to cold blood cardioplegia in adult patients undergoing elective aortic arch replacement?
Mean Difference: 1.23 (95% CI -2.89–4.12)
Absolute Event Rate: 59.5% vs 58.3%
p-value: p=0.0041 for noninferiority
Cold crystalloid cardioplegia offers a practical and similarly effective alternative to cold blood cardioplegia for preserving left ventricular function following elective aortic arch surgery requiring prolonged ischemia.
Crystalloid cardioplegia offers a practical alternative in aortic arch replacement; confirms noninferiority to blood cardioplegia for LVEF preservation.
Background: The optimal cardioplegic solution to use during aortic surgery remains unclear. While cold blood cardioplegia (BCP) has metabolic advantages, crystalloid cardioplegia (CCP) offers practical benefits. This trial investigated whether cold CCP is noninferior to cold BCP in preserving postoperative left ventricular ejection fraction (LVEF). Methods: In this single-center, patient- and assessor-blinded, parallel-group noninferiority randomized trial, 52 adult patients undergoing elective aortic arch replacement were randomized 1:1 to receive cold BCP or CCP. The primary endpoint was LVEF on postoperative day 7. The noninferiority margin was set at -7%. Secondary endpoints included change in LVEF, mortality, low-output syndrome, myocardial infarction (MI), creatine kinase MB isotype (CK-MB) release, left ventricular diastolic dysfunction, right ventricular systolic dysfunction, stroke, atrial fibrillation, pacemaker implantation, mediastinal drainage, reexploration for bleeding, and acute kidney injury. Results: = .034 and .046, respectively). One in-hospital death occurred in the BCP group, and 1 case of low output syndrome occurred in the CCP group. Postoperative MI occurred in 4 patients (2 per group), with no significant differences in other secondary endpoints. Conclusions: Cold CCP appeared to be noninferior to cold BCP for myocardial protection in elective aortic arch replacement, as suggested by comparable postoperative LVEF.
No takes yet. Share an insight, caveat, or question.
Hasegawa et al. (2026) conducted an RCT in Elective aortic arch replacement (n=52). Cold crystalloid cardioplegia vs. Cold blood cardioplegia was evaluated on Left ventricular ejection fraction (LVEF) on postoperative day 7 (MD 1.23%, 95% CI -2.89 to 4.12, p=0.0041 for noninferiority). Cold crystalloid cardioplegia preserved postoperative left ventricular ejection fraction as effectively as cold blood cardioplegia (mean difference 1.23%), meeting the predefined noninferiority margin of -7%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: